Cargando…
From functional genomics of vero cells to CRISPR‐based genomic deletion for improved viral production rates
Despite their wide use in the vaccine manufacturing field for over 40 years, one of the main limitations to recent efforts to develop Vero cells as high‐throughput vaccine manufacturing platforms is the lack of understanding of virus‐host interactions during infection and cell‐based virus production...
Autores principales: | Sène, Marie‐Angélique, Xia, Yu, Kamen, Amine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540595/ https://www.ncbi.nlm.nih.gov/pubmed/35869699 http://dx.doi.org/10.1002/bit.28190 |
Ejemplares similares
-
Haplotype-resolved de novo assembly of the Vero cell line genome
por: Sène, Marie-Angélique, et al.
Publicado: (2021) -
Comparative Transcriptomic Analyses of a Vero Cell Line in Suspension versus Adherent Culture Conditions
por: Sène, Marie-Angélique, et al.
Publicado: (2023) -
Vero cell upstream bioprocess development for the production of viral vectors and vaccines
por: Kiesslich, Sascha, et al.
Publicado: (2020) -
Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures
por: Kiesslich, Sascha, et al.
Publicado: (2021) -
Whole-Genome Sequencing of Vero E6 (VERO C1008) and Comparative Analysis of Four Vero Cell Sublines
por: Konishi, Kazuhiro, et al.
Publicado: (2022)